logo
Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2025

Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2025

Business Wire3 days ago
MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial results for the second quarter ended June 30, 2025.
Second Quarter Consolidated Results
Reported revenue increased 2.7% to $414.2 million in the second quarter of 2025 versus last year's second quarter results of $403.5 million. On a local currency basis (1), revenue increased 2.1%.
Reported operating income increased 16.2% to $57.7 million compared to $49.7 million recorded in the second quarter of 2024. In the second quarter of 2025, the Company recorded $3.3 million of costs related to its Portfolio Optimization Plan versus last year's $1.8 million in the second quarter. Local currency adjusted operating income (1) and local currency adjusted EBITDA (1) increased 16.9% and 14.1%, respectively, in the second quarter.
Reported earnings per share increased 20.5% to 88 cents in the second quarter of 2025 compared to 73 cents in the second quarter of 2024. Local currency adjusted diluted EPS (1) increased 20.8% in the second quarter.
'Sensient continued to build on a strong first quarter. Our results are a testament to our relentless focus on customer service and innovation. I remain very confident about our performance in 2025 and beyond,' said Paul Manning, Sensient's Chairman, President, and Chief Executive Officer.
The Flavors & Extracts Group reported second quarter 2025 revenue of $203.3 million, a decrease of $6.0 million versus the prior year's second quarter. The Group's revenue was unfavorably impacted by lower volumes in natural ingredients, partially offset by higher volumes in our flavors, extracts, and flavor ingredients product lines. Segment operating income was $28.5 million in the second quarter of 2025, an increase of $2.3 million compared to the prior year's second quarter. The segment operating income increased despite the decline in segment revenues due to strong profitability of the flavors, extracts, and flavor ingredients product lines.
The Color Group reported revenue of $179.3 million in the second quarter of 2025, an increase of $11.6 million compared to the prior year's second quarter. The Group's revenue increase was driven by strong growth in the food and pharmaceutical product lines. Segment operating income was $38.9 million in the second quarter of 2025, an increase of $7.4 million compared to the prior year's second quarter results.
The Asia Pacific Group reported revenue of $42.7 million in the second quarter of 2025, an increase of $4.2 million compared to the prior year's second quarter. The Group's revenue increased across nearly all geographies. Segment operating income was $8.9 million in the quarter, an increase of $1.1 million compared to the prior year's second quarter.
Corporate & Other reported operating expenses of $18.7 million in the second quarter of 2025, compared to $15.9 million of operating expenses reported in the prior year's second quarter. The higher operating expenses were primarily due to higher Portfolio Optimization Plan costs in the quarter. Local currency adjusted operating expenses (1) for Corporate & Other increased $1.1 million compared to the prior year's second quarter, primarily due to higher performance-based compensation costs recorded in 2025.
2025 OUTLOOK
The Company's guidance is based on current conditions and economic and market trends in the markets in which the Company operates and is subject to various risks and uncertainties as described below.
USE OF NON-GAAP FINANCIAL MEASURES
The Company's non-GAAP financial measures eliminate the impact of certain items, which, depending on the measure, include: currency movements, depreciation and amortization, Portfolio Optimization Plan costs, and non-cash share-based compensation. These measures are provided to enhance the overall understanding of the Company's performance when viewed together with the GAAP results. Refer to ' Reconciliation of Non-GAAP Amounts ' at the end of this release.
CONFERENCE CALL
The Company will host a conference call to discuss its 2025 second quarter financial results at 8:30 a.m. CDT on Friday, July 25, 2025. To participate in the conference call, contact Chorus Call Inc. at (844) 492-3726 or (412) 317-1078, and ask to join the Sensient Technologies Corporation conference call. Alternatively, the call can be accessed by using the webcast link that is available on the Investor Information section of the Company's web site at www.sensient.com.
A replay of the call will be available one hour after the end of the conference call through August 1, 2025, by calling (877) 344-7529 and using access code 2167989. An audio replay and written transcript of the call will also be posted on the Investor Information section of the Company's web site at www.sensient.com on or after July 29, 2025.
This release contains statements that may constitute 'forward-looking statements' within the meaning of Federal securities laws including in the quote from our Chairman, President, and Chief Executive Office and under '2025 Outlook' above. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors concerning the Company's operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company's future financial performance include the following: the Company's ability to manage general business, economic, and capital market conditions, including actions taken by customers in response to such market conditions, and the impact of recessions and economic downturns; the impact of macroeconomic and geopolitical volatility, including inflation and shortages impacting the availability and cost of raw materials, energy, and other supplies, disruptions and delays in the Company's supply chain, and the conflicts between Russia and Ukraine and in the Middle East; industry, regulatory, legal, and economic factors related to the Company's domestic and international business; the effects of tariffs, trade barriers, and disputes; the availability and cost of labor, logistics, and transportation; the pace and nature of new product introductions by the Company and the Company's customers; the Company's ability to anticipate and respond to changing consumer preferences, changing technologies, and changing regulations; the Company's ability to successfully implement its growth strategies; the outcome of the Company's various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and Portfolio Optimization Plan; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; the Company's ability to enhance its innovation efforts and drive cost efficiencies; currency exchange rate fluctuations; and other factors included in 'Risk Factors' in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and in other documents that the Company files with the SEC. The risks and uncertainties identified above are not the only risks the Company faces. Additional risks and uncertainties not presently known to the Company or that it currently believes to be immaterial also may adversely affect the Company. Should any known or unknown risks and uncertainties develop into actual events, these developments could have material adverse effects on our business, financial condition, and results of operations. This release contains time-sensitive information that reflects management's best analysis only as of the date of this release. Except to the extent required by applicable laws, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied herein will not be realized.
ABOUT SENSIENT TECHNOLOGIES
Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. Sensient uses advanced technologies and robust global supply chain capabilities to develop specialized solutions for food and beverages, as well as products that serve the pharmaceutical, nutraceutical, and personal care industries. Sensient's customers range in size from small entrepreneurial businesses to major international manufacturers representing some of the world's best-known brands. Sensient is headquartered in Milwaukee, Wisconsin.
Sensient Technologies Corporation
(In thousands)
(Unaudited)
Consolidated Condensed Balance Sheets
June 30,
December 31,
2025
2024
Cash and cash equivalents
$
56,686
$
26,626
Trade accounts receivable
333,951
290,087
Inventories
619,595
600,302
Prepaid expenses and other current assets
54,221
44,871
Fixed assets held for sale
1,629
-
Total Current Assets
1,066,082
961,886
Goodwill & intangible assets (net)
451,942
423,658
Property, plant, and equipment (net)
515,469
491,587
Other assets
171,068
146,663
Total Assets
$
2,204,561
$
2,023,794
Trade accounts payable
$
121,442
$
139,052
Short-term borrowings
26,280
19,848
Other current liabilities
103,402
111,739
Total Current Liabilities
251,124
270,639
Long-term debt
710,119
613,523
Accrued employee and retiree benefits
26,865
24,499
Other liabilities
59,332
54,147
Shareholders' Equity
1,157,121
1,060,986
Total Liabilities and Shareholders' Equity
$
2,204,561
$
2,023,794
Expand
Sensient Technologies Corporation
(In thousands, except per share amounts)
(Unaudited)
Consolidated Statements of Cash Flows
Six Months Ended June 30,
2025
2024
Cash flows from operating activities:
Net earnings
$
72,049
$
61,872
Adjustments to arrive at net cash provided by operating activities:
Depreciation and amortization
30,334
29,725
Share-based compensation expense
6,639
4,911
Net loss (gain) on assets
76
(195
)
Portfolio Optimization Plan costs
1,274
1,495
Deferred income taxes
2,711
529
Changes in operating assets and liabilities:
Trade accounts receivable
(30,293
)
(49,449
)
Inventories
(548
)
36,730
Prepaid expenses and other assets
(11,028
)
(6,612
)
Trade accounts payable and other accrued expenses
(17,578
)
(22,722
)
Accrued salaries, wages, and withholdings
(15,129
)
7,824
Income taxes
(937
)
(6,591
)
Other liabilities
1,734
1,429
Net cash provided by operating activities
39,304
58,946
Cash flows from investing activities:
Acquisition of property, plant, and equipment
(38,035
)
(22,850
)
Proceeds from sale of assets
56
296
Acquisition of new business
(4,867
)
-
Other investing activities
1,354
(336
)
Net cash used in investing activities
(41,492
)
(22,890
)
Cash flows from financing activities:
Proceeds from additional borrowings
106,484
132,189
Debt payments
(43,148
)
(120,571
)
Dividends paid
(34,700
)
(34,685
)
Other financing activities
(2,648
)
(3,016
)
Net cash provided by (used in) financing activities
25,988
(26,083
)
Effect of exchange rate changes on cash and cash equivalents
6,260
(8,568
)
Net increase in cash and cash equivalents
30,060
1,405
Cash and cash equivalents at beginning of period
26,626
28,934
Cash and cash equivalents at end of period
$
56,686
$
30,339
Supplemental Information
Six Months Ended June 30,
2025
2024
Dividends paid per share
$
0.82
$
0.82
Expand
Sensient Technologies Corporation
(In thousands, except percentages and per share amounts)
(Unaudited)
Reconciliation of Non-GAAP Amounts
The Company's results for the three and six months ended June 30, 2025 and 2024 include adjusted operating income, adjusted net earnings, and adjusted diluted earnings per share, which, in each case, exclude Portfolio Optimization Plan costs.
Three Months Ended June 30,
Six Months Ended June 30,
2025
2024
% Change
2025
2024
% Change
Operating income (GAAP)
$
57,706
$
49,657
16.2
%
$
111,236
$
99,063
12.3
%
Portfolio Optimization Plan costs – Cost of products sold
1,789
207
3,603
314
Portfolio Optimization Plan costs – Selling and administrative expenses
1,550
1,545
2,600
4,250
Adjusted operating income
$
61,045
$
51,409
18.7
%
$
117,439
$
103,627
13.3
%
Net earnings (GAAP)
$
37,587
$
30,932
21.5
%
$
72,049
$
61,872
16.4
%
Portfolio Optimization Plan costs, before tax
3,339
1,752
6,203
4,564
Tax impact of Portfolio Optimization Plan costs (1)
(815
)
(214
)
(1,517
)
(569
)
Adjusted net earnings
$
40,111
$
32,470
23.5
%
$
76,735
$
65,867
16.5
%
Diluted earnings per share (GAAP)
$
0.88
$
0.73
20.5
%
$
1.69
$
1.46
15.8
%
Portfolio Optimization Plan costs, net of tax
0.06
0.04
0.11
0.09
Adjusted diluted earnings per share
$
0.94
$
0.77
22.1
%
$
1.80
$
1.56
15.4
%
Note: Earnings per share calculations may not foot due to rounding differences.
(1) Tax impact adjustments were determined based on the nature of the underlying non-GAAP adjustments and their relevant jurisdictional tax rates.
Results by Segment
Three Months Ended June 30,
Adjusted
Adjusted
Operating Income
2025
Adjustments (2)
2025
2024
Adjustments (2)
2024
Flavors & Extracts
$
28,506
$
-
$
28,506
$
26,209
$
-
$
26,209
Color
38,922
-
38,922
31,502
-
31,502
Asia Pacific
8,943
-
8,943
7,880
-
7,880
Corporate & Other
(18,665
)
3,339
(15,326
)
(15,934
)
1,752
(14,182
)
Consolidated
$
57,706
$
3,339
$
61,045
$
49,657
$
1,752
$
51,409
Results by Segment
Six Months Ended June 30,
Adjusted
Adjusted
Operating Income
2025
Adjustments (2)
2025
2024
Adjustments (2)
2024
Flavors & Extracts
$
53,495
$
-
$
53,495
$
49,887
$
-
$
49,887
Color
73,774
-
73,774
63,181
-
63,181
Asia Pacific
18,385
-
18,385
16,656
-
16,656
Corporate & Other
(34,418
)
6,203
(28,215
)
(30,661
)
4,564
(26,097
)
Consolidated
$
111,236
$
6,203
$
117,439
$
99,063
$
4,564
$
103,627
(2) Adjustments consist of Portfolio Optimization Plan costs.
Expand
Sensient Technologies Corporation
(Unaudited)
Reconciliation of Non-GAAP Amounts - Continued
The following table summarizes the percentage change in the 2025 results compared to the 2024 results for the corresponding periods.
Three Months Ended June 30, 2025
Revenue Total Foreign
Exchange
Rates Adjustments (3) Local
Currency
Adjusted
Flavors & Extracts
(2.8
%)
0.4
%
N/A
(3.2
%)
Color
6.9
%
0.3
%
N/A
6.6
%
Asia Pacific
10.8
%
3.2
%
N/A
7.6
%
Total Revenue
2.7
%
0.6
%
N/A
2.1
%
Operating Income
Flavors & Extracts
8.8
%
0.2
%
0.0
%
8.6
%
Color
23.6
%
1.5
%
0.0
%
22.1
%
Asia Pacific
13.5
%
5.5
%
0.0
%
8.0
%
Corporate & Other
17.1
%
0.0
%
9.0
%
8.1
%
Total Operating Income
16.2
%
1.9
%
(2.6
%)
16.9
%
Diluted Earnings Per Share
20.5
%
1.3
%
(1.6
%)
20.8
%
Adjusted EBITDA
15.4
%
1.3
%
N/A
14.1
%
Six Months Ended June 30, 2025
Revenue Total Foreign
Exchange
Rates Adjustments (3) Local
Currency
Adjusted
Flavors & Extracts
(1.3
%)
(0.4
%)
N/A
(0.9
%)
Color
5.9
%
(1.5
%)
N/A
7.4
%
Asia Pacific
7.3
%
1.1
%
N/A
6.2
%
Total Revenue
2.3
%
(0.8
%)
N/A
3.1
%
Operating Income
Flavors & Extracts
7.2
%
(0.3
%)
0.0
%
7.5
%
Color
16.8
%
(1.0
%)
0.0
%
17.8
%
Asia Pacific
10.4
%
2.9
%
0.0
%
7.5
%
Corporate & Other
12.3
%
0.0
%
4.2
%
8.1
%
Total Operating Income
12.3
%
(0.3
%)
(1.0
%)
13.6
%
Diluted Earnings Per Share
15.8
%
0.0
%
(0.2
%)
16.0
%
Adjusted EBITDA
11.7
%
(0.4
%)
N/A
12.1
%
(3) Adjustments consist of Portfolio Optimization Plan costs.
Expand
Sensient Technologies Corporation
(In thousands, except percentages)
(Unaudited)
Reconciliation of Non-GAAP Amounts - Continued
The following table summarizes the reconciliation between Operating Income (GAAP) and Adjusted EBITDA for the three and six months ended June 30, 2025 and 2024.
Three Months Ended June 30,
Six Months Ended June 30,
2025
2024
% Change
2025
2024
% Change
Operating income (GAAP)
$
57,706
$
49,657
16.2
%
$
111,236
$
99,063
12.3
%
Depreciation and amortization
15,260
15,016
30,334
29,725
Share-based compensation expense
3,739
2,916
6,639
4,911
Portfolio Optimization Plan costs, before tax
3,339
1,752
6,203
4,564
Adjusted EBITDA
$
80,044
$
69,341
15.4
%
$
154,412
$
138,263
11.7
%
The following table summarizes the reconciliation between Debt (GAAP) and Net Debt, and Operating Income (GAAP) and Credit Adjusted EBITDA for the trailing twelve months ended June 30, 2025 and 2024.
June 30,
Debt
2025
2024
Short-term borrowings
$
26,280
$
26,995
Long-term debt
710,119
634,663
Credit Agreement adjustments (4)
(43,393
)
(18,034
)
Net Debt
$
693,006
$
643,624
Operating income (GAAP)
$
203,752
$
151,657
Depreciation and amortization
60,938
58,955
Share-based compensation expense
11,812
9,078
Portfolio Optimization Plan costs, before tax
8,270
32,405
Other non-operating gains (5)
(816
)
(872
)
Credit Adjusted EBITDA
$
283,956
$
251,223
Net Debt to Credit Adjusted EBITDA 2.4x 2.6x
(4) Adjustments include cash and cash equivalents, as described in the Company's Fourth Amended and Restated Credit Agreement (Credit Agreement), and certain letters of credit and hedge contracts.
(5) Adjustments consist of certain financing transaction costs, certain non-financing interest items, and gains and losses related to certain non-cash, non-operating, and/or non-recurring items as described in the Credit Agreement.
We have included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable period-over-period performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this release and our SEC filings. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends, and we believe the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies.
Expand
Category: Earnings
Source: Sensient Technologies Corporation
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Yahoo

time31 minutes ago

  • Yahoo

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio

Johnson & Johnson (JNJ) Adjusts Revenue and EPS Outlook; Stifel Hikes Price Target
Johnson & Johnson (JNJ) Adjusts Revenue and EPS Outlook; Stifel Hikes Price Target

Yahoo

time31 minutes ago

  • Yahoo

Johnson & Johnson (JNJ) Adjusts Revenue and EPS Outlook; Stifel Hikes Price Target

Johnson & Johnson (NYSE:JNJ) ranks among the . On July 16, Stifel maintained its Hold rating on Johnson & Johnson (NYSE:JNJ), but increased its price target for the healthcare giant from $155 to $165. The price target increase comes after JNJ revised its outlook, which now predicts adjusted operational revenue growth of roughly 3.5% instead of the 2.5% midpoint estimate that was previously projected. Pixabay/Public Domain Johnson & Johnson (NYSE:JNJ) also raised its outlook for full-year earnings per share from $10.50 to $10.70 to a range of $10.80 to $10.90. The company cited stronger top-line performance, currency effects, and a lower anticipated impact from tariffs for this improvement. From its initial estimate of $400 million, the healthcare company now projects a $200 million tariff impact in 2025. Johnson & Johnson (NYSE:JNJ) is a notable name in the healthcare industry, which includes sub-sectors like pharmaceuticals, medical equipment, and consumer health products. The company is known for creating medications to treat a variety of conditions and diseases, including cancer, diabetes, and HIV/AIDS. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None.

VAALCO Schedules Second Quarter 2025 Earnings Release and Conference Call
VAALCO Schedules Second Quarter 2025 Earnings Release and Conference Call

Yahoo

time31 minutes ago

  • Yahoo

VAALCO Schedules Second Quarter 2025 Earnings Release and Conference Call

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) ('Vaalco' or the 'Company') today announced the timing of its second quarter 2025 earnings release and conference call. The Company will issue its second quarter 2025 earnings release on Thursday, August 7, 2025 after the close of trading on the New York Stock Exchange and host a conference call to discuss its financial and operational results on Friday morning, August 8, 2025 at 9:00 a.m. Central Time (10:00 a.m. Eastern Time and 3:00 p.m. London Time.) Interested parties in the United States may participate toll-free by dialing (833) 685-0907. Interested parties in the United Kingdom may participate toll-free by dialing 08082389064. Other international parties may dial (412) 317-5741. Participants should ask to be joined to the 'Vaalco Energy Earnings Conference Call.' This call will also be webcast on VAALCO's website at An audio replay will be available on the Company's website following the call. About Vaalco Vaalco, founded in 1985 and incorporated under the laws of Delaware, is a Houston, Texas, USA based, independent energy company with a diverse portfolio of production, development and exploration assets across Gabon, Egypt, Côte d'Ivoire, Equatorial Guinea, Nigeria and Canada. For Further Information Vaalco Energy, Inc. (General and Investor Enquiries) +00 1 713 543 3422 Website: Al Petrie Advisors (US Investor Relations) +00 1 713 543 3422 Al Petrie / Chris Delange Buchanan (UK Financial PR) +44 (0) 207 466 5000 Ben Romney / Barry Archer Vaalco@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store